Progression of tumors and metastasis in particular is one of the main reasons of the high mortality rate among cancer patients. The primary role in developing metastases plays cell locomotion which requires remodeling of the actin cytoskeleton. Form, dynamics, localization and mechanical properties of the actin cytoskeleton are regulated by a variety of actin-binding proteins, which include the adenylyl cyclase-associated protein 1 (CAP1). The study is devoted to the investigation of CAP1 level depending on the presence or absence of metastases in patients with squamous cell carcinoma of the head and neck (SCCHN) and non-small cell lung cancer (NSCLC). The results show the contribution of CAP1 to SCCHN and NSCLC progression. We detected the connection between the tissue protein CAP1 level and the stage of NSCLC and SCCHN disease. Also the levels of the CAP1 protein in tissues of primary tumors and metastases in lung cancer were different. Our data showed that CAP is important in the development of metastases, which suggests further perspectives in the study of this protein for projecting metastasis of NSCLC and SCCHN.

1.
V. I.
Chissov
, in
Malignancies in Russia in 2011 (Morbidity and Mortality)
, edited by
V. I.
Chissov
,
V. V.
Starinskaya
, and
G. V.
Petrova
(
P. Herzen MORI “Russian Ministry of Health”
,
Moscow
,
2013
), p.
289
.
2.
M.
Muhamedov
,
D.
Kulbakin
,
E.
Choynzonov
,
V.
Gunther
,
T.
Chekalkin
, and
V.
Hodorenko
,
J. Surg. Onc.
111
(
2
),
231
236
(
2015
).
3.
G. V.
Kakurina
,
I. V.
Kondakova
, and
E. L.
Choinzonov
,
Vopr. Onkol.
58
(
1
),
26
32
(
2012
).
4.
G. V.
Kakurina
,
I. V.
Kondakova
,
O. V.
Cheremisina
,
D. A.
Shishkin
, and
E. L.
Choinzonov
,
Bull. Exp. Biol. Med.
160
(
5
),
695
697
(
2016
).
5.
D.
Ksiazek
,
H.
Brandstetter
,
L.
Israel
,
G. P.
Bourenkov
,
G.
Katchalova
,
K. P.
Janssen
,
H. D.
Bartunik
,
A. A.
Noegel
,
M.
Schleicher
, and
T. A.
Holak
,
Structure
11
(
9
),
1171
1178
(
2003
).
6.
E.
Bertling
,
P.
Hotulainen
,
P. K.
Mattila
,
T.
Matilainen
,
M.
Salminen
, and
P.
Lappalainen
,
Mol. Biol. Cell
15
(
5
),
2324
2334
(
2004
).
7.
S.
Lee
,
H.-Ch.
Lee
,
Y.-W.
Kwon
,
S. E.
Lee
,
Y.
Cho
,
J.
Kim
,
S.
Lee
,
J. Y.
Kim
,
J.
Lee
,
H. M.
Yang
,
I.
Mook-Jung
,
K. Y.
Nam
,
J.
Chung
,
M. A.
Lazar
, and
H. S.
Kim
,
Cell Metabolism
19
(
3
),
484
497
(
2014
).
8.
M.
Makkonen
,
E.
Bertling
,
N. A.
Chebotareva
,
J.
Baum
, and
P.
Lappalainen
,
J. Biol. Chem.
288
(
2
),
984
994
, (
2013
).
9.
X. F.
Yu
,
Q. C.
Ni
,
J. P.
Chen
,
J. F.
Xu
,
Y.
Jiang
,
S. Y.
Yang
,
J.
Ma
,
X. L.
Gu
,
H.
Wang
, and
Y. Y.
Wang
,
Exp. Mol. Pathol.
96
,
188
194
(
2014
).
10.
S. S.
Xie
,
M.
Tan
,
H. Y.
Lin
,
L.
Xu
,
C. X.
Shen
,
Q.
Yuan
,
X. L.
Song
, and
C. H.
Wang
,
Oncol. Rep.
33
(
1
),
363
371
(
2015
).
11.
M.
Hua
,
S.
Yan
,
Y.
Deng
,
Q.
Xi
,
R.
Liu
,
S.
Yang
,
J.
Liu
,
C.
Tang
,
Y.
Wang
, and
J.
Zhong
,
Int. J. Mol. Med.
35
(
4
),
941
949
(
2015
).
12.
H.
Zhang
,
P.
Ghai
,
H.
Wu
,
C.
Wang
,
J.
Field
, and
G. L.
Zhou
,
J. Biol. Chem.
288
(
29
),
20966
20977
(
2013
).
13.
K.
Yamazaki
,
M.
Takamura
,
Y.
Masugi
,
T.
Mori
,
W.
Du
,
T.
Hibi
,
N.
Hiraoka
,
T.
Ohta
,
M.
Ohki
,
S.
Hirohashi
, and
M.
Sakamoto
,
Lab. Invest.
89
(
4
),
425
432
(
2009
).
14.
X.
Liu
,
N.
Yao
,
J.
Qian
, and
H.
Huang
.
Med. Oncol.
31
(
3
),
878
(
2014
).
15.
C.
Wang
,
G. L.
Zhou
,
S.
Vedantam
,
P.
Li
, and
J.
Field
,
J. Cell Sci.
121
(
17
),
2913
2920
(
2008
).
This content is only available via PDF.
You do not currently have access to this content.